FDA Inspection 1217681 — Bioindustria Laboratorio Italiano Medicinali S.P.A
The FDA completed an inspection of Bioindustria Laboratorio Italiano Medicinali S.P.A on Feb 24, 2023 in Novi Ligure. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Novi Ligure (Italy)
Additional details
Mutual Recognition Agreement (MRA)